{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:24:03Z","timestamp":1791257043957,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Duke University School of Medicine Opioid Collaboratory portfolio"},{"DOI":"10.13039\/100000886","name":"Duke Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>No population-based studies have examined chronic opioid use among cancer survivors who are diverse with respect to diagnosis, age group, and insurance status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study using North Carolina cancer registry data linked with claims from public and private insurance (2006-2016). We included adults with nonmetastatic cancer who had no prior chronic opioid use (n\u2009=\u200938 366). We used modified Poisson regression to assess the adjusted relative risk of chronic opioid use in survivorship (&amp;gt;90-day continuous supply of opioids in the 13-24\u2009months following diagnosis) associated with patient characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Only 3.0% of cancer survivors in our cohort used opioids chronically in survivorship. Predictors included younger age (adjusted risk ratio [aRR] 50-59 vs 60-69\u2009=\u20091.23, 95% confidence interval [CI] = 1.05 to 1.43), baseline depression (aRR = 1.22, 95% CI = 1.06 to 1.41) or substance use (aRR = 1.43, 95% CI = 1.15 to 1.78) and Medicaid (aRR vs private = 1.93, 95% CI = 1.56 to 2.40). Survivors who used opioids intermittently (vs not at all) before diagnosis were twice as likely to use opioids chronically in survivorship (aRR = 2.62, 95% CI = 2.28 to 3.02). Those who used opioids chronically (vs intermittently or not at all) during active treatment had a nearly 17-fold increased likelihood of chronic use in survivorship (aRR = 16.65, 95% CI = 14.30 to 19.40).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Younger and low-income survivors, those with baseline depression or substance use, and those who require chronic opioid therapy during treatment are at increased risk for chronic opioid use in survivorship. Our findings point to opportunities to improve assessment of psychosocial histories and to engage patients in shared decision-making around long-term pain management, when chronic opioid therapy is required during treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djab082","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T21:13:06Z","timestamp":1618866786000},"page":"1581-1589","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims"],"prefix":"10.1093","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-879X","authenticated-orcid":false,"given":"Devon K","family":"Check","sequence":"first","affiliation":[{"name":"Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Baggett","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyungSu","family":"Kim","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W","family":"Roberts","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3434-2773","authenticated-orcid":false,"given":"Megan C","family":"Roberts","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-0668","authenticated-orcid":false,"given":"Timothy","family":"Robinson","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C","family":"Oeffinger","sequence":"additional","affiliation":[{"name":"Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela A","family":"Dinan","sequence":"additional","affiliation":[{"name":"Yale School of Public Health, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"issue":"4","key":"2021110218552620400_djab082-B1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"2021110218552620400_djab082-B2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M18-2864","article-title":"Patterns of opioid administration among opioid-naive inpatients and associations with postdischarge opioid use: a cohort study","volume":"171","author":"Donohue","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"2021110218552620400_djab082-B3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMsa1610524","article-title":"Opioid-prescribing patterns of emergency physicians and risk of long-term use","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"2021110218552620400_djab082-B4","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1213\/ANE.0000000000002458","article-title":"Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic","volume":"125","author":"Hah","year":"2017","journal-title":"Anesth Analg"},{"issue":"4","key":"2021110218552620400_djab082-B5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/15360288.2012.734908","article-title":"Chronic pain in cancer survivors: a growing issue","volume":"26","author":"van den Beuken-van Everdingen","year":"2012","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"6","key":"2021110218552620400_djab082-B6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"2021110218552620400_djab082-B7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jamaoncol.2019.1439","article-title":"Prevalence of chronic pain and high-impact chronic pain in cancer survivors in the United States","volume":"5","author":"Jiang","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"2021110218552620400_djab082-B8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.18.00938","article-title":"Trends in opioid use among older survivors of colorectal, lung, and breast cancers","volume":"37","author":"Salz","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021110218552620400_djab082-B9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.32593","article-title":"New-onset persistent opioid use following breast cancer treatment in older adult women","volume":"126","author":"Roberts","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"2021110218552620400_djab082-B10","first-page":"265","article-title":"Big data for population-based cancer research: the integrated cancer information and surveillance system","volume":"75","author":"Meyer","year":"2014","journal-title":"N C Med J"},{"issue":"7","key":"2021110218552620400_djab082-B11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jnci\/djz200","article-title":"Predicting persistent opioid use, abuse, and toxicity among cancer survivors","volume":"112","author":"Vitzthum","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2021110218552620400_djab082-B12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/pm\/pnw058","article-title":"The 1-year treatment course of new opioid recipients in Veterans Health Administration","volume":"17","author":"Mosher","year":"2016","journal-title":"Pain Med"},{"issue":"12","key":"2021110218552620400_djab082-B13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"2021110218552620400_djab082-B14"},{"issue":"7","key":"2021110218552620400_djab082-B15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2021110218552620400_djab082-B16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/pds.3934","article-title":"Prescription opioid exposures and adverse outcomes among older adults","volume":"25","author":"West","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"2021110218552620400_djab082-B17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2021110218552620400_djab082-B18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jgo.2014.10.003","article-title":"Systematic review of falls in older adults with cancer","volume":"6","author":"Wildes","year":"2015","journal-title":"J Geriatr Oncol"},{"issue":"12","key":"2021110218552620400_djab082-B19","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.pain.2013.07.029","article-title":"Prevalence and impact of pain among older adults in the United States: findings from the 2011 National Health and Aging Trends Study","volume":"154","author":"Patel","year":"2013","journal-title":"Pain"},{"issue":"10","key":"2021110218552620400_djab082-B20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3928\/0098-9134-19951001-05","article-title":"Assessment of acute and chronic pain in older adults","volume":"21","author":"Forrest","year":"1995","journal-title":"J Gerontol Nurs"},{"issue":"7","key":"2021110218552620400_djab082-B21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/M19-0492","article-title":"Care fragmentation and prescription opioids","volume":"170","author":"Meyer","year":"2019","journal-title":"Ann Intern Med"},{"key":"2021110218552620400_djab082-B22","first-page":"395","article-title":"Exploring factors associated with long-term opioid therapy in cancer survivors: an integrative review","volume-title":"J Pain Symptom Manage","author":"Jones","year":"2021"},{"key":"2021110218552620400_djab082-B23"},{"issue":"9","key":"2021110218552620400_djab082-B24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jpain.2011.04.002","article-title":"Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection","volume":"12","author":"Miaskowski","year":"2011","journal-title":"J Pain"},{"issue":"4","key":"2021110218552620400_djab082-B25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/09540121.2020.1748866","article-title":"Predictors of pain-related functional impairment among people living with HIV on long-term opioid therapy","volume":"33","author":"Serota","year":"2021","journal-title":"AIDS Care"},{"issue":"1","key":"2021110218552620400_djab082-B26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/002214650604700102","article-title":"Financial strain over the life course and health among older adults","volume":"47","author":"Kahn","year":"2006","journal-title":"J Health Soc Behav"},{"issue":"3","key":"2021110218552620400_djab082-B27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/rep0000261","article-title":"Personal resource profiles of individuals with chronic pain: sociodemographic and pain interference differences","volume":"64","author":"Mun","year":"2019","journal-title":"Rehabil Psychol"},{"issue":"5","key":"2021110218552620400_djab082-B28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1467-8721.2009.01650.x","article-title":"Socioeconomic status and health: What is the role of reserve capacity?","volume":"18","author":"Gallo","year":"2009","journal-title":"Curr Dir Psychol Sci"},{"issue":"2","key":"2021110218552620400_djab082-B29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pmn.2019.08.005","article-title":"Racial and socioeconomic factors associated with the use of complementary and alternative modalities for pain in cancer outpatients: an integrative review","volume":"21","author":"Ludwick","year":"2020","journal-title":"Pain Manag Nurs"},{"issue":"10","key":"2021110218552620400_djab082-B30","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/pm\/pnz087","article-title":"What if acupuncture were covered by insurance for pain management? A cross-sectional study of cancer patients at one academic center and 11 community hospitals","volume":"20","author":"Liou","year":"2019","journal-title":"Pain Med"},{"issue":"3","key":"2021110218552620400_djab082-B31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jpainsymman.2004.04.007","article-title":"Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history","volume":"28","author":"Michna","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"2021110218552620400_djab082-B32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2006.06.010","article-title":"Nonmedical use of prescription drugs among a longitudinal sample of dependent and problem drinkers","volume":"86","author":"Matzger","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"27","key":"2021110218552620400_djab082-B33","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"issue":"12","key":"2021110218552620400_djab082-B34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00005650-200412000-00002","article-title":"Clinician screening and treatment of alcohol, drug, and mental problems in primary care: results from healthcare for communities","volume":"42","author":"Edlund","year":"2004","journal-title":"Med Care"},{"issue":"4","key":"2021110218552620400_djab082-B35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/djaa122","article-title":"Opioid use disorder and overdose in older adults with breast, colorectal, or prostate cancer","volume":"113","author":"Roberts","year":"2021","journal-title":"J Natl Cancer Inst"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djab082\/39073743\/djab082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/11\/1581\/41053611\/djab082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/11\/1581\/41053611\/djab082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T21:37:55Z","timestamp":1635889075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/113\/11\/1581\/6244179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,4,21]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djab082","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,4,21]]}}}